| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director +2 more
43 companies
Ra Capital Management, L.P. is a Director, 10% Owner at WVE with holdings across 43 companies. Recent SEC Form 4 filings include 17 buys and 16 sells.
Estimated insider holdings value: $3402.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | COAG Hemab Therapeutics Holdings, Inc. Common Stock | 10% Owner | Buy | 67,669 | $24.97 | $1,689,818.48 | +0.5% | - | - | |
| Jun 11, 2026 | ARTV Artiva Biotherapeutics, Inc. | Director, 10% Owner | Buy | 1,027,722 | $7.44 | $7,650,148.29 | +2.2% | - | - | |
| Jun 11, 2026 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell | 678,226 | $0.37 | $253,568.65 | -3.9% | - | - | |
| May 11, 2026 | ARTV Artiva Biotherapeutics, Inc. | Director, 10% Owner | Buy | 6,510,416 | $11.52 | $74,999,992.32 | +74.9% | - | - | |
| May 11, 2026 | COAG Hemab Therapeutics Holdings, Inc. Common Stock | 10% Owner | Buy | 51,258 | $24.75 | $1,268,594.26 | +0.2% | - | - | |
| May 6, 2026 | COAG Hemab Therapeutics Holdings, Inc. Common Stock | Director, 10% Owner | Buy | 2,840,429 | $18.39 | $52,222,945.65 | +9.9% | - | - | |
| Apr 22, 2026 | VOR Vor Biopharma Inc. | Director, 10% Owner | Sell | 165,150 | $15.77 | $2,604,415.50 | -6.4% | - | - | |
| Apr 20, 2026 | VOR Vor Biopharma Inc. | Director, 10% Owner | Sell | 630,374 | $16.14 | $10,174,787.59 | -10.6% | - | - | |
| Apr 15, 2026 | VOR Vor Biopharma Inc. | Director, 10% Owner | Sell | 737,989 | $16.10 | $11,883,339.89 | -7.0% | - | - | |
| Apr 10, 2026 | VOR Vor Biopharma Inc. | Director, 10% Owner | Sell | 620,133 | $16.50 | $10,233,811.45 | -3.7% | - | - |